Cite
HARVARD Citation
Houede, N. et al. (n.d.). 2594 Safety and efficacy of Temsirolimus (Torisel®) as second line treatment for patients with recurrent bladder cancer. European journal of cancer. pp. S509-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Houede, N. et al. (n.d.). 2594 Safety and efficacy of Temsirolimus (Torisel®) as second line treatment for patients with recurrent bladder cancer. European journal of cancer. pp. S509-. [Online].